Further to DrugAlert Volume 930, HPS Pharmacies wish to provide an update on the action required for the product defect correction and recall of Panadol® Children 1 Month – 1 Year:
Panadol Children 1 Month – 1 Year
Paracetamol 100 mg/mL
ARTG 83363
The following batches are affected by this notice:
- DR562 (Exp 30/04/2024)
- DR563 (Exp 30/04/2024)
- DT528 (Exp 30/04/2024)
- DS947 (Exp 31/07/2024)
- DS956 (Exp 31/08/2024)
- DT334 (Exp 30/09/2024)
- DT469 (Exp 30/09/2024)
- DT762 (Exp 31/10/2024)
- DT912 (Exp 31/10/2024)
- DU128 (Exp 30/11/2024)
- DT913 (Exp 31/10/2024)
- DW301 (Exp 28/02/2025)
- DW507 (Exp 28/02/2025)
- DW487 (Exp 28/02/2025)
This defect correction was initiated as the supplied dosing syringe may be stiff and difficult to use. This may make it difficult to control the delivery of the medicine and may pose a risk of choking. There are no safety or quality problems with the liquid medicine itself.
Action required:
- Affected stock located within pharmacies should be quarantined for return to the supplier.
- Imprest stock from the affected batches may continue to be used. However, the supplied dosing syringe must be discarded and replaced with an appropriate alternative.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Haleon on 1800 028 533 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates